Page last updated: 2024-10-17

creatine and Local Neoplasm Recurrence

creatine has been researched along with Local Neoplasm Recurrence in 39 studies

Research Excerpts

ExcerptRelevanceReference
"Thirteen patients with recurrent glioblastoma were enrolled in RTOG 0625/ACRIN 6677, a prospective multicenter trial in which bevacizumab was used in combination with either temozolomide or irinotecan."5.17Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677. ( Barboriak, DP; Bokstein, F; Boxerman, JL; Gilbert, MR; McKinstry, RC; Ratai, EM; Safriel, Y; Snyder, BS; Sorensen, AG; Zhang, Z, 2013)
"Age and choline/creatine ratio are strong independent prognostic factors in high grade gliomas."3.81Prognostic Value of MRS Metabolites in Postoperative Irradiated High Grade Gliomas. ( Kelekis, N; Kokakis, I; Kouloulias, V; Kouvaris, JR; Kyrgias, G; Mosa, E; Papathanasiou, M; Pissakas, G; Pistevou-Gombaki, K; Tolia, M; Tsoukalas, N; Verganelakis, D, 2015)
" Primary central nervous system lymphoma (PCNSL) is a highly aggressive tumor responsive to high-dose methotrexate based regimens."3.73Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma. ( Abrey, LE; DeAngelis, LM; Koutcher, JA; Lis, E; Panageas, KS; Raizer, JJ; Xu, S; Zakian, KL, 2005)
"Seven patients responded to tamoxifen therapy (three with glioblastomas multiforme; four with anaplastic astrocytomas), and nine did not (six with glioblastomas multiforme; three with anaplastic astrocytomas)."3.70Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy. ( Arnold, DL; Caramanos, Z; Langleben, A; LeBlanc, R; Preul, MC; Shenouda, G; Villemure, JG, 2000)
"Postradiation treatment necrosis is one of the most serious late sequelae and appears within 6 months."3.01Brain magnetic resonance spectroscopy to differentiate recurrent neoplasm from radiation necrosis: A systematic review and meta-analysis. ( Aseel, A; McCarthy, P; Mohammed, A, 2023)
"There were no significant adverse effects from FLT injected at a dose of 0."2.73NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studies. ( Eary, JF; Hoffman, JM; Krohn, KA; Link, JM; Muzi, M; Spence, AM, 2008)
"necrosis in patients with primary brain tumors or brain metastasis."2.53Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis. ( Chen, YC; Chuang, MT; Liu, YS; Tsai, YS; Wang, CK, 2016)
"When MRS and MR imaging agree on prostate cancer presence, the positive predictive value is about 80-90%."2.44Proton MR spectroscopy of the prostate. ( Mueller-Lisse, UG; Scherr, MK, 2007)
"This supports long-term HT in advanced prostate cancer."1.38Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy. ( Bonomo, P; Clementi, V; D'Agostino, GR; Di Molfetta, IV; Gui, B; Mantini, G; Mattiucci, G; Valentini, AL, 2012)
"The histological diagnosis was anaplastic oligodendroglioma (WHO grade III)."1.37[Usefulness of quantitative H-MR spectroscopy for the differentiation between radiation necrosis and recurrence of anaplastic oligodendroglioma]. ( Akutsu, H; Anno, I; Isobe, T; Masumoto, T; Matsumura, A; Nakai, K; Shiigai, M; Takano, S; Yamamoto, T, 2011)
"Necrosis was present histologically in four of the five meningiomas classified either as atypical or papillary."1.30Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. ( Handa, J; Inubushi, T; Matsuda, M; Morikawa, S; Nakasu, S; Shino, A, 1999)
"Thirteen cases of brain cancer treated by radiation therapy were examined by 1H magnetic resonance spectroscopy and gadolinium-enhanced T1-weighted magnetic resonance imaging and reexamined at 2-month intervals."1.29Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast. ( Levendag, PC; Oudkerk, M; Sijens, PE; van Dijk, P; Vecht, CJ, 1995)
"Surgical specimens of squamous cell carcinoma arising from the upper aerodigestive tract (n = 18) and from muscle (n = 13) were examined in vitro using high-field (11 T) proton MR spectroscopy."1.29Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics. ( Blackstock, W; Castillo, M; Kwock, L; Mukherji, SK; Schiro, S; Shockley, W; Soper, R; Weissler, M, 1996)
"A phase I trial and pharmacokinetic study of 5-aza-2'-deoxycytidine (5-aza-dCyd) were conducted in 21 patients with advanced solid tumors."1.27Phase I and pharmacokinetic study of 5-aza-2'-deoxycytidine (NSC 127716) in cancer patients. ( Gall, HE; Leyva, A; O'Brien, AM; Pinedo, HM; van Groeningen, CJ, 1986)

Research

Studies (39)

TimeframeStudies, this research(%)All Research%
pre-19902 (5.13)18.7374
1990's8 (20.51)18.2507
2000's18 (46.15)29.6817
2010's9 (23.08)24.3611
2020's2 (5.13)2.80

Authors

AuthorsStudies
Feng, A1
Yuan, P1
Huang, T1
Li, L1
Lyu, J1
Aseel, A1
McCarthy, P1
Mohammed, A1
Ratai, EM1
Zhang, Z1
Snyder, BS1
Boxerman, JL1
Safriel, Y1
McKinstry, RC1
Bokstein, F1
Gilbert, MR1
Sorensen, AG1
Barboriak, DP1
Deviers, A1
Ken, S1
Filleron, T1
Rowland, B1
Laruelo, A1
Catalaa, I1
Lubrano, V1
Celsis, P1
Berry, I1
Mogicato, G1
Cohen-Jonathan Moyal, E1
Laprie, A2
Tolia, M1
Verganelakis, D1
Tsoukalas, N1
Kyrgias, G1
Papathanasiou, M1
Mosa, E1
Kokakis, I1
Kouvaris, JR1
Pissakas, G1
Pistevou-Gombaki, K1
Kelekis, N1
Kouloulias, V1
Chuang, MT1
Liu, YS1
Tsai, YS1
Chen, YC1
Wang, CK1
Spence, AM1
Muzi, M1
Link, JM1
Hoffman, JM1
Eary, JF1
Krohn, KA1
Smith, EA2
Carlos, RC2
Junck, LR1
Tsien, CI1
Elias, A1
Sundgren, PC3
Matsusue, E1
Fink, JR1
Rockhill, JK1
Ogawa, T1
Maravilla, KR1
Goenka, AH1
Kumar, A1
Sharma, R1
Kirilova, A1
Damyanovich, A1
Crook, J1
Jezioranski, J1
Wallace, K1
Pintilie, M1
Isobe, T1
Akutsu, H1
Yamamoto, T1
Shiigai, M1
Masumoto, T1
Nakai, K1
Takano, S1
Anno, I1
Matsumura, A1
Elias, AE1
Frechtling, D1
George, B1
Maly, P2
Valentini, AL1
Gui, B1
D'Agostino, GR1
Mattiucci, G1
Clementi, V1
Di Molfetta, IV1
Bonomo, P1
Mantini, G1
Rock, JP1
Hearshen, D1
Scarpace, L1
Croteau, D1
Gutierrez, J1
Fisher, JL1
Rosenblum, ML1
Mikkelsen, T1
Mueller-Lisse, UG2
Scherr, M1
BRANDSTETTER, F1
GITSCH, E1
SCHULLER, E1
Lichy, MP1
Bachert, P1
Henze, M1
Lichy, CM1
Debus, J1
Schlemmer, HP1
Ando, K1
Ishikura, R1
Nagami, Y1
Morikawa, T1
Takada, Y1
Ikeda, J1
Nakao, N1
Matsumoto, T1
Arita, N1
Chan, AA1
Lau, A1
Pirzkall, A2
Chang, SM1
Verhey, LJ1
Larson, D2
McDermott, MW1
Dillon, WP3
Nelson, SJ3
Plotkin, M1
Eisenacher, J1
Bruhn, H1
Wurm, R1
Michel, R1
Stockhammer, F1
Feussner, A1
Dudeck, O1
Wust, P1
Felix, R1
Amthauer, H1
Raizer, JJ1
Koutcher, JA1
Abrey, LE1
Panageas, KS1
DeAngelis, LM1
Lis, E1
Xu, S1
Zakian, KL1
Haas-Kogan, DA1
Cha, S1
Banerjee, A1
Le, TP1
Lu, Y1
Nelson, S1
McKnight, TR1
Weybright, P1
Hassan, DG1
Nan, B1
Rohrer, S1
Junck, L1
Zeng, QS1
Li, CF1
Zhang, K1
Liu, H2
Kang, XS1
Zhen, JH1
Scherr, MK1
Sijens, PE1
Vecht, CJ1
Levendag, PC1
van Dijk, P1
Oudkerk, M1
Mukherji, SK1
Schiro, S1
Castillo, M1
Kwock, L1
Soper, R1
Blackstock, W1
Shockley, W1
Weissler, M1
Tedeschi, G1
Lundbom, N1
Raman, R1
Bonavita, S1
Duyn, JH1
Alger, JR2
Di Chiro, G1
Wald, LL1
Day, MR1
Noworolski, SE1
Henry, RG1
Huhn, SL1
Chang, S2
Prados, MD2
Sneed, PK2
Larson, DA1
Wara, WM1
McDermott, M2
Gutin, PH1
Vigneron, DB2
Kinoshita, K1
Tada, E1
Matsumoto, K1
Asari, S1
Ohmoto, T1
Itoh, T1
Burtscher, IM1
Ståhlberg, F1
Holtås, S1
Lazareff, JA1
Bockhorst, KH1
Curran, J1
Olmstead, C1
Shino, A1
Nakasu, S1
Matsuda, M1
Handa, J1
Morikawa, S1
Inubushi, T1
Preul, MC1
Caramanos, Z1
Villemure, JG1
Shenouda, G1
LeBlanc, R1
Langleben, A1
Arnold, DL1
Graves, EE1
Chin, C1
Verhey, L1
Lamborn, K1
Ricci, PE1
Pitt, A1
Keller, PJ1
Coons, SW1
Heiserman, JE1
Hall, WA1
Martin, AJ1
Truwit, CL1
van Groeningen, CJ1
Leyva, A1
O'Brien, AM1
Gall, HE1
Pinedo, HM1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
NCI-Sponsored Trial for the Evaluation of Safety and Preliminary Efficacy Using [F18] Fluorothymidine (FLT) As a Marker of Proliferation in Patients With Primary Brain Tumors[NCT00276770]12 participants (Actual)Interventional2006-02-28Completed
Multi-paramEtric Imaging to Assess Treatment REsponse After Stereotactic Radiosurgery of Brain Metastases[NCT04626206]12 participants (Anticipated)Observational2020-12-31Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for creatine and Local Neoplasm Recurrence

ArticleYear
Brain magnetic resonance spectroscopy to differentiate recurrent neoplasm from radiation necrosis: A systematic review and meta-analysis.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2023, Volume: 33, Issue:2

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Child; Child, Preschool; Choline; Cr

2023
Differentiating Radiation-Induced Necrosis from Recurrent Brain Tumor Using MR Perfusion and Spectroscopy: A Meta-Analysis.
    PloS one, 2016, Volume: 11, Issue:1

    Topics: Aspartic Acid; Blood Volume; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Hum

2016
[1H magnetic resonance spectroscopy of the prostate].
    Der Radiologe, 2003, Volume: 43, Issue:6

    Topics: Biopsy; Choline; Citrates; Creatine; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Magnetic

2003
Proton MR spectroscopy of the prostate.
    European journal of radiology, 2007, Volume: 63, Issue:3

    Topics: Biopsy; Choline; Citric Acid; Creatine; Diagnosis, Differential; Humans; Imaging, Three-Dimensional;

2007

Trials

4 trials available for creatine and Local Neoplasm Recurrence

ArticleYear
Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677.
    Neuro-oncology, 2013, Volume: 15, Issue:7

    Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Be

2013
Evaluation of the lactate-to-N-acetyl-aspartate ratio defined with magnetic resonance spectroscopic imaging before radiation therapy as a new predictive marker of the site of relapse in patients with glioblastoma multiforme.
    International journal of radiation oncology, biology, physics, 2014, Oct-01, Volume: 90, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Aspartic Acid; Biomarkers, Tumor; Brain Neoplasms; Choline; Crea

2014
NCI-sponsored trial for the evaluation of safety and preliminary efficacy of FLT as a marker of proliferation in patients with recurrent gliomas: safety studies.
    Molecular imaging and biology, 2008, Volume: 10, Issue:5

    Topics: Adult; Biomarkers; Carbon Dioxide; Cell Proliferation; Creatine; Dideoxynucleosides; Drug-Related Si

2008
Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
    Journal of neuro-oncology, 2007, Volume: 84, Issue:1

    Topics: Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Fema

2007

Other Studies

31 other studies available for creatine and Local Neoplasm Recurrence

ArticleYear
Distinguishing Tumor Recurrence From Radiation Necrosis in Treated Glioblastoma Using Multiparametric MRI.
    Academic radiology, 2022, Volume: 29, Issue:9

    Topics: Brain Neoplasms; Choline; Creatine; Diffusion Magnetic Resonance Imaging; Diffusion Tensor Imaging;

2022
Prognostic Value of MRS Metabolites in Postoperative Irradiated High Grade Gliomas.
    BioMed research international, 2015, Volume: 2015

    Topics: Adult; Age Factors; Aged; Choline; Creatine; Disease-Free Survival; Female; Glioma; Humans; Magnetic

2015
Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions.
    AJR. American journal of roentgenology, 2009, Volume: 192, Issue:2

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Contrast

2009
Distinction between glioma progression and post-radiation change by combined physiologic MR imaging.
    Neuroradiology, 2010, Volume: 52, Issue:4

    Topics: Adult; Aspartic Acid; Blood Volume; Brain; Brain Neoplasms; Cerebrovascular Circulation; Choline; Cr

2010
MR spectroscopy for differentiation of recurrent glioma from radiation-induced changes.
    AJR. American journal of roentgenology, 2009, Volume: 193, Issue:6

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Contrast

2009
3D MR-spectroscopic imaging assessment of metabolic activity in the prostate during the PSA "bounce" following 125iodine brachytherapy.
    International journal of radiation oncology, biology, physics, 2011, Feb-01, Volume: 79, Issue:2

    Topics: Brachytherapy; Choline; Citric Acid; Creatine; Humans; Iodine Radioisotopes; Magnetic Resonance Imag

2011
[Usefulness of quantitative H-MR spectroscopy for the differentiation between radiation necrosis and recurrence of anaplastic oligodendroglioma].
    No shinkei geka. Neurological surgery, 2011, Volume: 39, Issue:5

    Topics: Adult; Aspartic Acid; Brain Diseases; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; F

2011
MR spectroscopy using normalized and non-normalized metabolite ratios for differentiating recurrent brain tumor from radiation injury.
    Academic radiology, 2011, Volume: 18, Issue:9

    Topics: Adolescent; Adult; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Creatine; Diagn

2011
Locally advanced prostate cancer: three-dimensional magnetic resonance spectroscopy to monitor prostate response to therapy.
    International journal of radiation oncology, biology, physics, 2012, Nov-01, Volume: 84, Issue:3

    Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Choline; Combined Moda

2012
Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.
    Neurosurgery, 2002, Volume: 51, Issue:4

    Topics: Adult; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Glioma; Humans; Lactic Acid; Lip

2002
[Effects of vitamin E on kreatinin metabolism in recurrent female genital carcinoma].
    Zentralblatt fur Gynakologie, 1955, Volume: 77, Issue:2

    Topics: Carcinoma; Creatine; Female; Genitalia; Genitalia, Female; Humans; Neoplasm Recurrence, Local; Neopl

1955
Monitoring individual response to brain-tumour chemotherapy: proton MR spectroscopy in a patient with recurrent glioma after stereotactic radiotherapy.
    Neuroradiology, 2004, Volume: 46, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Astrocytoma; Brain Neoplasms;

2004
[Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions].
    Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 2004, Volume: 64, Issue:3

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Choline; Creatine; Female; Glioma

2004
Proton magnetic resonance spectroscopy imaging in the evaluation of patients undergoing gamma knife surgery for Grade IV glioma.
    Journal of neurosurgery, 2004, Volume: 101, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Mapping; Brain Neoplasms; Choline; Cohor

2004
123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.
    Journal of neuro-oncology, 2004, Volume: 70, Issue:1

    Topics: Adult; Aged; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Female; Glioblastoma; Huma

2004
Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
    Journal of neuro-oncology, 2005, Volume: 71, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Aspartic Acid; Central Nervous Syst

2005
Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    International journal of radiation oncology, biology, physics, 2005, May-01, Volume: 62, Issue:1

    Topics: Aspartic Acid; Brain Stem Neoplasms; Child; Child, Preschool; Choline; Creatine; Disease Progression

2005
Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
    AJR. American journal of roentgenology, 2005, Volume: 185, Issue:6

    Topics: Adolescent; Adult; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Contrast Media;

2005
Hydrogen magnetic resonance spectroscopy follow-up after radiation therapy of human brain cancer. Unexpected inverse correlation between the changes in tumor choline level and post-gadolinium magnetic resonance imaging contrast.
    Investigative radiology, 1995, Volume: 30, Issue:12

    Topics: Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Energy Metabolism; Follow-Up Studies; Four

1995
Proton MR spectroscopy of squamous cell carcinoma of the upper aerodigestive tract: in vitro characteristics.
    AJNR. American journal of neuroradiology, 1996, Volume: 17, Issue:8

    Topics: Carcinoma, Squamous Cell; Choline; Confidence Intervals; Creatine; Esophageal Neoplasms; Esophagus;

1996
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
    Journal of neurosurgery, 1997, Volume: 87, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cell Transformation, Neoplas

1997
Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.
    Journal of neurosurgery, 1997, Volume: 87, Issue:4

    Topics: Aspartic Acid; Brachytherapy; Brain; Brain Neoplasms; Choline; Contrast Media; Creatine; Disease Pro

1997
Proton MR spectroscopy of delayed cerebral radiation in monkeys and humans after brachytherapy.
    AJNR. American journal of neuroradiology, 1997, Volume: 18, Issue:9

    Topics: Adult; Animals; Aspartic Acid; Brachytherapy; Brain; Brain Neoplasms; Choline; Cranial Irradiation;

1997
Proton (1H) MR spectroscopy for routine diagnostic evaluation of brain lesions.
    Acta radiologica (Stockholm, Sweden : 1987), 1997, Volume: 38, Issue:6

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Diseases; Brain Neo

1997
Pediatric low-grade gliomas: prognosis with proton magnetic resonance spectroscopic imaging.
    Neurosurgery, 1998, Volume: 43, Issue:4

    Topics: Adolescent; Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Cell Division; Child; Child, Prescho

1998
Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
    Journal of neurosurgery, 1999, Volume: 91, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antigens, Nuclear; Biomarkers, Tumor; Brain; Cell Division; Cell Tra

1999
Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy.
    Neurosurgery, 2000, Volume: 46, Issue:2

    Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents, Hormonal; Aspartic Acid; Astro

2000
A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas.
    Neurosurgery, 2000, Volume: 46, Issue:2

    Topics: Adult; Aged; Aspartic Acid; Astrocytoma; Choline; Creatine; Female; Glioblastoma; Humans; Lactic Aci

2000
Effect of voxel position on single-voxel MR spectroscopy findings.
    AJNR. American journal of neuroradiology, 2000, Volume: 21, Issue:2

    Topics: Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Glio

2000
An efficient chemical shift imaging scheme for magnetic resonance-guided neurosurgery.
    Journal of magnetic resonance imaging : JMRI, 2001, Volume: 14, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Astrocytoma; Biopsy; Brain; Brain Mapping; Brain Neop

2001
Phase I and pharmacokinetic study of 5-aza-2'-deoxycytidine (NSC 127716) in cancer patients.
    Cancer research, 1986, Volume: 46, Issue:9

    Topics: Adult; Aged; Azacitidine; Creatine; Decitabine; Dose-Response Relationship, Drug; Drug Administratio

1986